Not Open Access | Intravenous β-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation
The study compared the in vivo pharmacodynamic efficacy of ARM NLC with C-AST in a murine model. For this study, the Peters 4 day suppressive test was adopted. Plasmodium berghei was the causative organism for inducing malaria in mice.